Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium

Authors :: Özgür M Koc
Bert Aertgeerts
Pavlos Mamouris
Rob Bielen
Dana Busschots
Geert Goderis
Geert Robaeys
Frederik Nevens
Catharina Matheï
Bert Vaes
RS: NUTRIM - R2 - Liver and digestive health
Medische Microbiologie
Promovendi NTM
Source :: BMJ Open, BMJ Open, 9(5):026464, 1-9. BMJ Publishing Group
Publication Year :: 2019
Publisher :: BMJ Publishing Group, 2019.
Abstract: Objectives Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) have a major impact on mortality worldwide. Although effective treatments are available for both HBV and HCV infection

Subjects :: Male
HBsAg
General Practice
medicine.disease_cause
testing policy
0302 clinical medicine
Belgium
general practitioners
Risk Factors
INFECTION
EPIDEMIOLOGY
PLUS SOFOSBUVIR
Registries
030212 general & internal medicine
education.field_of_study
Medical record
PRIMARY-CARE
virus diseases
Viral hepatitis b
General Medicine
Middle Aged
Hepatitis B
Hepatitis C
PREVALENCE
Female
030211 gastroenterology & hepatology
General practice / Family practice
Viral hepatitis
RIBAVIRIN
Life Sciences & Biomedicine
viral hepatitis
Adult
medicine.medical_specialty
Hepatitis C virus
Population
03 medical and health sciences
Medicine, General & Internal
Internal medicine
General & Internal Medicine
medicine
Humans
Serologic Tests
education
Hepatitis B virus
CHRONIC HCV
Hepatitis B Surface Antigens
Community level
Science & Technology
business.industry
Research
Hepatitis C Antibodies
VIRUS GENOTYPE 1
medicine.disease
digestive system diseases
Logistic Models
business

Tools